Postoperative Hip Precautions for Osteoarthritis
Trial Summary
What is the purpose of this trial?
The purpose of this study is to determine if hip precautions, which are instructions that limit functional use of a hip replacement after surgery, affect the rate of dislocation in the first six weeks after primary total hip replacement surgery. The impact of hip precautions on a patient's return to activities of daily living and overall patient satisfaction will also be investigated. The overall cost effectiveness of hip precautions will be determined.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What data supports the effectiveness of the treatment 'Postoperative Hip Precautions for Osteoarthritis'?
Research suggests that hip precautions, which are movement restrictions after hip surgery, do not significantly impact early recovery or reduce dislocation rates in patients with osteoarthritis undergoing total hip replacement. In fact, some studies indicate that these precautions may not provide additional benefits and could potentially slow down recovery.12345
Are hip precautions safe for humans after hip surgery?
How does the treatment of hip precautions differ from other treatments for osteoarthritis after hip replacement?
Hip precautions involve movement restrictions after hip replacement surgery to prevent dislocation, but recent studies suggest they may not be necessary and could hinder recovery. This approach is unique because it challenges the traditional practice of imposing movement limits, suggesting that some patients may recover just as well without these restrictions.12345
Research Team
Omar Behery, MD
Principal Investigator
Orthopedics Surgeon
Eligibility Criteria
This trial is for patients with noninflammatory arthritis who are having their first total hip replacement through the posterior approach. They must understand and follow study procedures but can't join if they have allergies to materials used in the study or previous major surgeries on the affected joint.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo total hip arthroplasty and are assigned to either receive or not receive hip precautions for the first six weeks after surgery
Follow-up
Participants are monitored for dislocation, use of assistive devices, and return to activities of daily living
Treatment Details
Interventions
- Hip Precautions (Behavioural Intervention)
- No Hip Precautions (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rush University Medical Center
Lead Sponsor
Dr. Omar B. Lateef
Rush University Medical Center
Chief Executive Officer since 2022
MD from Des Moines University, Fellowship in Pulmonary and Critical Care Medicine at Rush University Medical Center
Dr. Paul E. Casey
Rush University Medical Center
Chief Medical Officer since 2021
MD, MBA